ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MRSN Mersana Therapeutics Inc

0.7304
0.0104 (1.44%)
Pre Market
Last Updated: 09:08:05
Delayed by 15 minutes
Share Name Share Symbol Market Type
Mersana Therapeutics Inc NASDAQ:MRSN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0104 1.44% 0.7304 0.7301 0.75 51,541 09:08:05

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

24/12/2024 12:50am

Edgar (US Regulatory)


EXHIBIT 99.1

 

AGREEMENT REGARDING JOINT FILING

OF STATEMENT ON SCHEDULE 13D OR 13G

 

The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint EcoR1 Capital, LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise of the foregoing power, as fully as the undersigned might or could do if personally present.

 

Dated: December 23, 2024

 

 

ECOR1 CAPITAL, LLC


By: /s/ Oleg Nodelman
Oleg Nodelman
Manager

 

 

ECOR1 CAPITAL FUND QUALIFIED, L.P.

By: EcoR1 Capital, LLC,
General Partner

By: /s/ Oleg Nodelman
Oleg Nodelman
Manager

 

 

 

/s/ Oleg Nodelman

Oleg Nodelman


1 Year Mersana Therapeutics Chart

1 Year Mersana Therapeutics Chart

1 Month Mersana Therapeutics Chart

1 Month Mersana Therapeutics Chart